A
A
A
Home
Organisation
About Us
Mission and Objectives
Directorates and Units
Committees and Working Groups
Annual Reports
Heads of Medicines Agencies
Working at the Malta Medicines Authority
Career Opportunities
Bank and Payment Details
Data and Information
Freedom of Information
Data Protection
Presentations and Publications
Links
Medical Devices and Pharmaceutical Collaboration
Pharmacy Roster
eHealth
Government of Malta
Heads of Medicines Agency
Innovative Medicines Initiative
European Medicines Agency
Legislation
Introduction
Better Regulation
Legislation Documentation
Medicines Act
Medical Device Legislation
EU Legislation
Consultation
Collaboration
Request for Collaborative Agreements
EU & Medicines Authority Consultations
EU & Medicines Authority Consultations
News & Events
News
Press Releases
Circulars
Other News
Past News
Events
Latest Events
Past Events
Online Services
Online Services
Eudrapharm
EU Common Submission Portal
Medicines Authority Notifications
Servizz.gov.mt
Online Applications (E-Forms)
Newsletters
Contact and Connect
On Line Forms
Enquiries and Feedback
Complaints
Complaints related to Advertising of Medicinal Products
Report Product Defect
Report a Side Effect - Adverse Drug Reaction (ADR)
Connect and Share
Engage with us on Facebook
Follow us on LinkedIn
Follow us on Twitter
Connect with us on Google
Watch our videos on YouTube
Find Us
Contact Details
Previous
Next
Patient / Consumer
Know more about Medicines Regulation
Know more about access to medicines which do not have a Marketing Authorisation
Report a Side Effect
Biological and Biosimilar Medicinal Products
How we monitor the safety of medicines
Know more about the Medicines Supply Chain
Know more about Use of Medicines
Information Leaflets on Medicines
Search for your Medicines
Industry
Pharmaceutical Activities and Inspections
Product Quality Defects Reporting
Scientific Advice
Advertising
Registering a product
Pharmacovigilance
Fees
Health Care Professionals
Search Authorised Medicines in Malta
Adverse Drug Reaction Reporting
How we monitor the safety of medicinal products
Safety Information
Clinical Trials
Product Quality Defects Reporting
Medicines supply chain and regulation
Advertising
Home
/ Search Medicine Results
Search Medicine Results
Useful Links
Medical Devices and Pharmaceutical Collaboration
Pharmacy Roster
eHealth
Government of Malta
Heads of Medicines Agency
Innovative Medicines Initiative
European Medicines Agency
Activities
Pharmaceutical Activities and Inspections
Scientific Advice
Recalls and Rapid Alerts
Registration of Medicinal Products
Advertising
Borderline Products
Changes to prescription status
Safety Recalls
BREXIT - Regulatory considerations
Advanced Scientific Initiatives
Cannabis for Medicinal and Research Purposes
Linguistic Checks
Safety
Clinical Trials
Enforcement and Market Surveillance
Rifinah 300/150mg film-coated Tablets
Summary of Product
Patient Information
Authorisation Number:
MA1359/02802
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AM02
Pharmaceutical Form:
FILM-COATED TABLET
Active Ingredients:
ISONIAZID
RIFAMPICIN
Classification:
POM
Status:
Withdrawn
Authorised Pack Sizes:
56 or 100 tablets
Read More
Rifinah 150/100mg film-coated Tablets
Summary of Product
Patient Information
Authorisation Number:
MA1359/02801
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AM02
Pharmaceutical Form:
FILM-COATED TABLET
Active Ingredients:
ISONIAZID
RIFAMPICIN
Classification:
POM
Status:
Withdrawn
Authorised Pack Sizes:
84 or 100 tablets
Read More
Rifadin Intravenous 600mg powder and solvent for concentrate for solution for Infusion
Summary of Product
Patient Information
Authorisation Number:
MA1359/02701
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AB02
Pharmaceutical Form:
POWDER AND SOLVENT FOR SOLUTION FOR INFUSION
Active Ingredients:
RIFAMPICIN
Classification:
POM
Status:
Withdrawn
Authorised Pack Sizes:
20ml vial and 10ml glass ampoule
Read More
Rifadin 100mg/5ml Oral Suspension
Authorisation Number:
AA565/04104
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AB02
Pharmaceutical Form:
ORAL SUSPENSION
Active Ingredients:
RIFAMPICIN
Classification:
POM
Status:
Authorised
Authorised Pack Sizes:
120ml
Read More
Rifinah 150/100mg Tablets
Authorisation Number:
PI565/68301A
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AM02
Pharmaceutical Form:
TABLET
Active Ingredients:
RIFAMPICIN
ISONIAZID
Classification:
POM
Status:
Invalid
Authorised Pack Sizes:
84 tablels
Read More
Rifinah 300/150mg Coated Tablets
Authorisation Number:
PI565/68302A
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AM02
Pharmaceutical Form:
COATED TABLET
Active Ingredients:
RIFAMPICIN
ISONIAZID
Classification:
POM
Status:
Invalid
Authorised Pack Sizes:
56 or 100 tablets
Read More
Rifadin Oral suspension 20 mg/ml
Authorisation Number:
AA565/04105
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AB02
Pharmaceutical Form:
ORAL SUSPENSION
Active Ingredients:
RIFAMPICIN
Classification:
POM
Status:
Authorised
Authorised Pack Sizes:
60 and 180ml glass bottles
Read More
Rifadin, powder for infusion 600 mg
Authorisation Number:
PI565/04107A
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AB02
Pharmaceutical Form:
POWDER FOR INFUSION
Active Ingredients:
RIFAMPICIN
Classification:
POM
Status:
Authorised
Authorised Pack Sizes:
1 vial of powder plus separate solvent
Read More
EREMFAT IV 600 mg, powder for solution for infusion
Authorisation Number:
AA729/29401
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AB02
Pharmaceutical Form:
POWDER FOR SOLUTION FOR INFUSION
Active Ingredients:
RIFAMPICIN SODIUM
Classification:
POM
Status:
Authorised
Authorised Pack Sizes:
1 vial or 10 vials (hospital pack)
Read More
Rifamazid, 150 mg + 100 mg, hard capsules
Authorisation Number:
AA1404/00701
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AM02
Pharmaceutical Form:
HARD CAPSULE
Active Ingredients:
RIFAMPICIN
ISONIAZID
Classification:
POM
Status:
Authorised
Authorised Pack Sizes:
100 hard capsules
Read More
Rifamazid, 300 mg + 150 mg, hard capsules
Authorisation Number:
AA1404/00702
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AM02
Pharmaceutical Form:
HARD CAPSULE
Active Ingredients:
ISONIAZID
RIFAMPICIN
Classification:
POM
Status:
Authorised
Authorised Pack Sizes:
100 hard capsules
Read More
Sinerdol Iso 300 mg/150 mg Capsules
Authorisation Number:
AA1411/10501
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AM02
Pharmaceutical Form:
CAPSULE
Active Ingredients:
RIFAMPICIN
ISONIAZID
Classification:
POM
Status:
Authorised
Authorised Pack Sizes:
1x10 capsules, 100x10 capsules
Read More
Rifamazid, 150 mg + 100 mg, hard capsules
Authorisation Number:
AA565/81703
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AM02
Pharmaceutical Form:
HARD CAPSULE
Active Ingredients:
ISONIAZID
RIFAMPICIN
Classification:
POM
Status:
Authorised
Authorised Pack Sizes:
100 hard capsules
Read More
Rifampicyna TZF, 300 mg, hard capsules
Authorisation Number:
AA1404/00402
Therapeutic Class:
ANTIMYCOBACTERIALS
ATC Code:
J04AB02
Pharmaceutical Form:
HARD CAPSULE
Active Ingredients:
RIFAMPICIN
Classification:
POM
Status:
Authorised
Authorised Pack Sizes:
100 capsules
Read More
Page: 1 of 1